BO

Bonzun AB (publ )FNSE Bonzun AB Stock Report

Last reporting period 30 Sep, 2023

Updated 21 Oct, 2024

Last price

Market cap $B

0

Micro

Exchange

FNSE - First North Sweden

BONZUN.ST Stock Analysis

BO

Uncovered

Bonzun AB (publ ) is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-56/100

Low score

Market cap $B

0

Dividend yield

Shares outstanding

74.495 B

Bonzun AB engages in the development and production of research based digital programs that aids consumer to lower the risk of mental illness. The company is headquartered in Stockholm, Stockholm. The company went IPO on 2014-10-02. Its offering application, which helps users to has a better control over their life, health and wellbeing. The Companys main products are: Bonzun IVF is a personalized and complete IVF app, its smart tools and emotional support to increase chances to succeed with ART treatments IVF, ICSI or Frozen Embryo Transfer (FET); Bonzun evolve helps companies and their employees to develop and strengthen their self-leadership and coping mechanisms to deal with stressful situations in the work environment and Kou Dai Yun Yu app, the virtual midwife, helps pregnant women understand when it is time to seek a doctor and when it is safe to stay home.

View Section: Eyestock Rating